Dilated cardiomyopathy 1GG- MedGen UID:
- 462248
- •Concept ID:
- C3150898
- •
- Disease or Syndrome
Any familial isolated dilated cardiomyopathy in which the cause of the disease is a mutation in the SDHA gene.
Arterial calcification, generalized, of infancy, 2- MedGen UID:
- 477791
- •Concept ID:
- C3276161
- •
- Disease or Syndrome
Generalized arterial calcification of infancy (GACI) is characterized by infantile onset of widespread arterial calcification and/or narrowing of large and medium-sized vessels resulting in cardiovascular findings (which can include heart failure, respiratory distress, edema, cyanosis, hypertension, and/or cardiomegaly). Additional findings can include typical skin and retinal manifestations of pseudoxanthoma elasticum (PXE), periarticular calcifications, development of rickets after infancy, cervical spine fusion, and hearing loss. While mortality in infancy is high, survival into the third and fourth decades has occurred.
Cardiomyopathy, dilated, 2D- MedGen UID:
- 1782612
- •Concept ID:
- C5543535
- •
- Disease or Syndrome
Dilated cardiomyopathy-2D (CMD2D) is characterized by neonatal onset of severe cardiomyopathy, with rapid progression to cardiac decompensation and death unless the patient undergoes heart transplantation (Ganapathi et al., 2020).
For a general phenotypic description and a discussion of genetic heterogeneity of dilated cardiomyopathy, see 115200.
Myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy- MedGen UID:
- 1794147
- •Concept ID:
- C5561937
- •
- Disease or Syndrome
Infantile-onset myofibrillar myopathy-12 with cardiomyopathy (MFM12) is a severe autosomal recessive disorder affecting both skeletal and cardiac muscle tissue that is apparent in the first weeks of life. Affected infants show tremor or clonus at birth, followed by onset of rapidly progressive generalized muscle weakness and dilated cardiomyopathy and cardiac failure, usually resulting in death by 6 months of age. Skeletal and cardiac muscle tissues show hypotrophy of type I muscle fibers and evidence of myofibrillar disorganization (summary by Weterman et al., 2013).
For a discussion of genetic heterogeneity of myofibrillar myopathy, see MFM1 (601419).
Cardiomyopathy, dilated, 2G- MedGen UID:
- 1801983
- •Concept ID:
- C5676995
- •
- Disease or Syndrome
Dilated cardiomyopathy-2G (CMD2G) is characterized by early-onset severe dilated cardiomyopathy that progresses rapidly to heart failure in the neonatal period without evidence of intervening hypertrophy. Cardiac tissue exhibits markedly shortened thin filaments, disorganized myofibrils, and reduced contractile force generation, resulting in the severe ventricular dysfunction observed. There is no evidence of skeletal muscle hypertrophy (Ahrens-Nicklas et al., 2019).
For a general phenotypic description and a discussion of genetic heterogeneity of dilated cardiomyopathy, see 115200.